EurimPharm Arzneimittel GmbH
EurimPharm Arzneimittel GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe. Founded in 1994, the company has established itself as a trusted provider of high-quality generic medicines and innovative healthcare solutions. EurimPharm focuses on a diverse range of therapeutic areas, including pain management, cardiovascular health, and infectious diseases, offering a portfolio that stands out for its commitment to quality and affordability. With a strong emphasis on research and development, the company has achieved significant milestones, enhancing its market position as a reliable supplier in the competitive pharmaceutical landscape. Recognised for its dedication to patient care and safety, EurimPharm continues to expand its reach, ensuring that effective treatments are accessible to healthcare providers and patients alike.
DitchCarbon Score
How does EurimPharm Arzneimittel GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
EurimPharm Arzneimittel GmbH's score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
EurimPharm Arzneimittel GmbH's reported carbon emissions
EurimPharm Arzneimittel GmbH, headquartered in Germany, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, EurimPharm's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent or related organization. The company may need to establish clear climate strategies and targets to align with industry standards and enhance its sustainability profile.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
EurimPharm Arzneimittel GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
